Elisa T. Helbig

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau et al. · The Lancet Respiratory Medicine · 2021 · 355 citations · Full text

Life Sciences, Immunology, Immunization +13

Complement activation induces excessive T cell cytotoxicity in severe COVID-19

Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro et al. · Cell · 2021 · 227 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke et al. · Cell Systems · 2021 · 217 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses

Matteo Ugolini, Jenny Gerhard, Sanne Burkert et al. · Nature Immunology · 2018 · 172 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months

Fridolin Steinbeis, Charlotte Thibeault, Felix Doellinger et al. · Respiratory Medicine · 2021 · 107 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17